NeuroSense Therapeutics Ltd. (NRSNW) Stock Price

Live NeuroSense Therapeutics Ltd. Stock Price, Historical NRSNW Stock Price Chart

Quick Links

24H Range

52W Range

Last Price	$ 0.005500
Open	$ 0.005500
Previous Close	$ 0.005600
Volume	$ 5.00
ATH	$ 1.95 (-99.72%)
Exchange	NASDAQ
P/E Ratio (TTM)	0.00
EPS (TTM)	-$ 6.24
Annual Dividend (Yield)	-
Market Cap	$ 135,667

NeuroSense Therapeutics Ltd. Performance

Prev. Close	7 Days	1 Month	3 Months	6 Months	1 Year	YTD	5 Year	Max
-1.79%	-26.67%	-47.62%	-92.67%	-92.47%	-98.10%	-98.17%	-99.46%	-99.46%

About NeuroSense Therapeutics Ltd.

Statistics

The NeuroSense Therapeutics Ltd. stock price is currently $ 0.005500 with a total market cap valuation of $ 135,667 (24.67M shares outstanding). The NeuroSense Therapeutics Ltd. is trading on NASDAQ under the ticker sign NRSNW. NeuroSense Therapeutics Ltd. price is up -1.79% in the past 24 hours. The NeuroSense Therapeutics Ltd. stock price prediction is currently bullish.

Description

NeuroSense Therapeutics Ltd. is an Israeli clinical-stage biotechnology firm dedicated to pioneering novel therapies for severe neurodegenerative conditions. Its most advanced investigational asset is PrimeC, an innovative oral compound specifically engineered to address amyotrophic lateral sclerosis (ALS). Beyond its lead program, the company boasts a preclinical pipeline featuring StabiliC, aimed at Parkinson's disease, and CogniC, targeting Alzheimer's disease. Established in Herzliya, Israel, in 2017, NeuroSense Therapeutics continues to advance its therapeutic initiatives.